Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-Cis-Retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				EPO2006-AISSM04 2006-006482-16, NCT00804050

Last Modified: 1/15/2008 First Published: 2/21/2006


2.		Phase I/II Study of High-Dose Calcitriol and Temozolomide in Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				NU-05M1 NU-0310-093, SPRI-NU-05M1, NCT00301067


3.		Phase I/II Calcitriol in Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				Over 18				NCI, Other				UMCC 2008.042 HUM%21242, NCT00794547

Last Modified: 10/23/2008 First Published: 5/28/2004


4.		Phase II Randomized Pilot Study of Calcitriol and Dexamethasone Before Radical Prostatectomy in Patients With Localized Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				RPCI-RP-0212 NCT00084864


5.		Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				No age specified				Other				FD-R-2025-01 FD-R-002025-01, NCT00030069


6.		The Role of Calcipotriol as Radioprotector of Skin

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Approved-not yet active				18 to 75				Other				004253 NCT00445250

Last Modified: 8/27/2008 First Published: 6/3/2008


7.		Phase I Pilot Study of Calcitriol in Smokers or Former Smokers With Squamous Metaplasia or Squamous Dysplasia of the Lungs

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Active				40 to 79				NCI				RPCI-I-90206 I 90205, NCT00690924

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute